JAK inhibitor | dermcity

Nov 13 min read

JAK inhibitors for alopecia areata

JAK inhibitors are emerging as effective treatments for alopecia areata, said Ottawa-based dermatologist Dr. Jennifer Beecker during a...

Oct 182 min read

TEN treated successfully with JAK inhibitor

Researchers have successfully treated seven patients experiencing toxic epidermal necrolysis (TEN) using JAK inhibitors. All seven...

Jun 142 min read

Abrocitinib improves chronic itching conditions

New research shows that the Janus kinase (JAK) inhibitor abrocitinib, approved in Canada for the treatment of moderate-to-severe atopic...

Jan 152 min read

Precise design of JAK inhibitors may improve outcomes in variety of diseases

A study from the Icahn School of Medicine at Mount Sinai in New York has reported some new insights into JAK inhibitors. While current...

Jun 23, 20231 min read

JAK inhibitors may treat eosinophilic cellulitis

New findings suggest that eosinophilic cellulitis (EC) preferentially activates the Janus kinase (JAK) 1/JAK2-STAT5 pathways. The...

Jun 2, 20233 min read

Disabling pansclerotic morphea treated with ruxolitinib

Researchers have identified genomic variants that cause disabling pansclerotic morphea and have identified a treatment for the rare,...

Apr 21, 20231 min read

Oral JAK inhibitor treats adolescent alopecia areata

New findings show that the oral Janus kinase (JAK) inhibitor ritlecitinib effectively treats alopecia areata in adolescents. The study...

Mar 28, 20222 min read

Baricitinib shows promise in alopecia areata

The results of two phase 3 trials of patients with severe alopecia areata (AA) indicate that oral baricitinib was superior to placebo...

1

Featured Posts